Article Text

PDF

355 A comparative study of vitamin d levels in autoimmune and non-autoimmune disease
  1. A bankole1,
  2. F Wong2,
  3. S Ford2,
  4. J McMunn2,
  5. Z Shahrear2 and
  6. J rawlins2
  1. 1Carilion Clinic, Rheumatology, Roanoke, USA
  2. 2Carilion Clinic, Internal Medicine, Roanoke, USA

Abstract

Background and aims Studies have shown an association between levels of Vitamin D and incidence and activity of autoimmune diseases. The purpose of this study was to examine correlation between vitamin D levels in RA and SLE patients compared to controls without autoimmune disease. Our hypothesis was that low vitamin D is ubiquitous in the general population and not related to specific autoimmune disease.

Methods This was a retrospective, single centre, hospital-affiliated outpatient cohort study. A systematic review of the electronic medical record generated a patient list with the diagnosis codes for RA, SLE, osteoarthritis (OA) and Fibromyalgia. Vitamin D levels were characterised as follows: deficiency (<20 ng/mL), insufficiency (20–30 ng/mL) and normal (>30 ng/ml). A total of 115 patents were included, and, SAS9.3 statistical tool was used to analyse the data.

Results A total of 23 patients had RA, 27 had SLE and 65 had non-inflammatory disease (OA and fibromyalgia). There was no statistically significant difference in the vitamin D levels in RA, SLE versus the non-inflammatory group.

We did note of interest that in the RA group, a body mass index (BMI) above 35 had lower Vitamin D levels, as opposed to the lupus and control group groups.

Abstract 355 Table 1
Abstract 355 Table 1
Abstract 355 Figure 1
Abstract 355 Figure 1

Conclusions In our study, we found no relationship between the levels of vitamin D levels and the presence or absence of autoimmune disease. We did find a relationship between the BMI and Vitamin D levels, and this will need further study.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.